Document ID: chunk:federal_register_of_legislation:F2024C01137:reg:2:p3
Version: federal_register_of_legislation:F2024C01137
Segment Type: reg
Provision Reference: reg 2 (pt 3/6)
Character Range: 26508–29377

Transaction to a Prescribed Repository, in compliance with the Alternative Reporting Requirements in at least one Foreign Jurisdiction; and
(B)       designated the information reported under paragraph (a) as information that has been reported under these Rules; or
           (ii)       the Reporting Entity is exempt from the requirement in all of the Foreign Jurisdictions to report information about the Reportable Transaction, or there is no requirement in any of the Foreign Jurisdictions to report information about the Reportable Transaction.

Exception for incomplete ISO 20022 message definition, delay for changed message definition
(4) A Reporting Entity is not required to comply with the requirements of subrule (1) and this Part that would otherwise apply to the Reporting Entity in relation to one or more items of Derivative Transaction Information set out in Part S1.3 of Schedule 1 about a Reportable Transaction:
         1.          if at the time the Reporting Entity is required to comply with the requirements, the ISO 20022 message definition used in accordance with subrule 2.2.4(2) does not include those items of Derivative Transaction Information; or
         2.        until the first Monday that occurs 7 months after the date of an approved change to the ISO 20022 message definition, if at the time the reporting entity is required to comply with the requirements, the changed ISO 20022 message definition has been in effect for a period of less than 7 months.

2.2.2 Reporting Requirement—Changes
(1) Where a Reporting Entity has reported information about an OTC Derivative and there is a change to the information reported that does not constitute a Reportable Transaction, the Reporting Entity must report the change, and also the applicable information about the change set out in Items 101 and 102 of Table S1.1(1), Item 13 of Table S1.1(2) and Item 22 of Table S1.1(3) in accordance with the requirements of this Part.
(2) Without limiting subrule (1) and subject to subrule (3), a Reporting Entity must report:
         1.         each updated valuation of the OTC Derivative, whether performed by the Reporting Entity or by another person on behalf of the Reporting Entity;
         2.        each updated collateral amount posted or collected in relation to the OTC Derivative; and
         3.         a change to the UTI of the OTC Derivative where a UTI has been generated and reported under subrule 2.2.9(6)(a) or (c)(ii) and, at a later time, the Reporting Entity receives a UTI from the UTI generating entity.
(3) If there is more than one update or change of the kind referred to in paragraphs (2)(a) or (b) during a Business Day, the Reporting Entity is only required to report the update or change that occurs closest to the end of that Business Day.

2.2.3 Reporting Requirement—Timing (generally, T+2)
(1) Subject to